The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

Spinal muscular atrophy (SMA), which is caused by inactivating mutations in the survival motor neuron 1 (SMN1) gene, is characterized by loss of lower motor neurons in the spinal cord. The gene encoding SMN is very highly conserved in evolution, allowing the disease to be modeled in a range of speci...

Полное описание

Библиографические подробности
Главные авторы:	Sleigh, J, Gillingwater, T, Talbot, K
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Схожие документы

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
по: James N. Sleigh, и др.
Опубликовано: (2011-07-01)

Spinal muscular atrophy at the crossroads of basic science and therapy
по: Sleigh, J, и др.
Опубликовано: (2013)

Spinal muscular atrophy at the crossroads of basic science and therapy.
по: Sleigh, J, и др.
Опубликовано: (2013)

Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.
по: Murray, L, и др.
Опубликовано: (2010)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
по: Wishart, T, и др.
Опубликовано: (2010)

Spinal muscular atrophy.
по: Talbot, K, и др.
Опубликовано: (2001)

Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.
по: Bäumer, D, и др.
Опубликовано: (2009)

Development and Translation of Therapies for Spinal Muscular Atrophy
по: Hannah K. Shorrock, и др.
Опубликовано: (2016-07-01)

Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
по: Murray, L, и др.
Опубликовано: (2008)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
по: Murray, L, и др.
Опубликовано: (2010)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
по: Bowerman, M, и др.
Опубликовано: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
по: Bowerman, M, и др.
Опубликовано: (2017)

Chapter 16 Spinal Muscular Atrophy
по: Talbot, K, и др.
Опубликовано: (2003)

Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.
по: Dirk Bäumer, и др.
Опубликовано: (2009-12-01)

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
по: Mutsaers, C, и др.
Опубликовано: (2011)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
по: Melissa Bowerman, и др.
Опубликовано: (2017-08-01)

Invertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.
по: Grice, S, и др.
Опубликовано: (2011)

Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
по: Grice, S, и др.
Опубликовано: (2011)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
по: Turner, B, и др.
Опубликовано: (2008)

Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.
по: Sleigh, J, и др.
Опубликовано: (2014)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
по: Ansorge Olaf, и др.
Опубликовано: (2008-10-01)

Model systems for exploring new therapeutic interventions and disease mechanisms in spinal muscular atrophies (SMAs)
по: Sleigh, JN
Опубликовано: (2012)

Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.
по: Penelope J Boyd, и др.
Опубликовано: (2017-04-01)

Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
по: Andrés López-Cortés, и др.
Опубликовано: (2022-06-01)

Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies.
по: Talbot, K, и др.
Опубликовано: (2007)

Spinal Muscular Atrophy
по: J Gordon Millichap
Опубликовано: (1990-02-01)

Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy.
по: Karen K Y Ling, и др.
Опубликовано: (2010-11-01)

Spinal muscular atrophy
по: D'Amico Adele, и др.
Опубликовано: (2011-11-01)

The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
по: Charlotte Spicer, и др.
Опубликовано: (2021-04-01)

Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy.
по: Sophie R Thomson, и др.
Опубликовано: (2012-01-01)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
по: Hammond, S, и др.
Опубликовано: (2016)

Modeling spinal muscular atrophy in Drosophila.
по: Chang, H, и др.
Опубликовано: (2008)

Modeling spinal muscular atrophy in Drosophila.
по: Howard Chia-Hao Chang, и др.
Опубликовано: (2008-09-01)

Spinal Muscular Atrophy and Arthrogryposis
по: J Gordon Millichap
Опубликовано: (1997-10-01)

Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.
по: Anderson, K, и др.
Опубликовано: (2003)

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY
по: Theodosiou, A, и др.
Опубликовано: (1995)

Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy
по: Christian M. Simon, и др.
Опубликовано: (2019-12-01)

Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
по: Andrew P. Tosolini, и др.
Опубликовано: (2017-12-01)

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy
по: Rocio Tejero, и др.
Опубликовано: (2020-02-01)

Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy
по: Jamie A. Johansen, и др.
Опубликовано: (2009-04-01)